Angewandte Chemie International Edition · 2013 · 78 citations · 13 references
MedicineBiochemistryMedicinal ChemistryDrug DesignEnzymologyHemostasisAnticoagulant TherapyAnticoagulation TherapyCalcium-binding ProteinsCoagulation CascadeCoagulation DisordersCoagulation PhysiologyActive Site StructureCalcium Binding DomainsCalcium Dependence In CoagulationCalcium-dependent CoagulationCoagulation Factor BindingFactor Viiia ComplexFactor Xiii FunctionNatural Anticoagulant Proteins
On active duty: The available drugs for cardiovascular diseases can promote blood clotting but can also lead to life-threatening bleeding episodes. A promising target for the development of safer alternatives is the transglutaminase Factor XIII (FXIII), the active structure of which is presented. The binding and coordination of three calcium ions induce major domain movements in the enzyme upon activation. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
13
Transglutaminase 2 Undergoes a Large Conformational Change upon Activation
Daniel M. Pinkas, Pavel Strop, Axel T. Brünger et al. · PLoS Biology · 2007 · 445 citations · Full text
Life Sciences, Biochemistry, Biology +16
On the Solubility of Fibrin Clots